- Home
- MAIN vs ACLX Comparison
MAIN vs ACLX Comparison
Compare MAIN & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIN
- ACLX
- Stock Information
- Founded
- MAIN 2007
- ACLX 2015
- Country
- MAIN United States
- ACLX United States
- Employees
- MAIN N/A
- ACLX N/A
- Industry
- MAIN Finance/Investors Services
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- MAIN Finance
- ACLX Health Care
- Exchange
- MAIN Nasdaq
- ACLX Nasdaq
- Market Cap
- MAIN 4.5B
- ACLX 5.3B
- IPO Year
- MAIN 2007
- ACLX 2022
- Fundamental
- Price
- MAIN $52.14
- ACLX $87.83
- Analyst Decision
- MAIN Hold
- ACLX Strong Buy
- Analyst Count
- MAIN 5
- ACLX 14
- Target Price
- MAIN $48.80
- ACLX $103.67
- AVG Volume (30 Days)
- MAIN 409.1K
- ACLX 667.5K
- Earning Date
- MAIN 11-07-2024
- ACLX 11-07-2024
- Dividend Yield
- MAIN 8.05%
- ACLX N/A
- EPS Growth
- MAIN 11.78
- ACLX N/A
- EPS
- MAIN 5.51
- ACLX N/A
- Revenue
- MAIN $529,897,000.00
- ACLX $155,818,000.00
- Revenue This Year
- MAIN $11.27
- ACLX $20.54
- Revenue Next Year
- MAIN $2.69
- ACLX N/A
- P/E Ratio
- MAIN $9.47
- ACLX N/A
- Revenue Growth
- MAIN 9.27
- ACLX 230.33
- 52 Week Low
- MAIN $40.51
- ACLX $46.42
- 52 Week High
- MAIN $52.89
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- MAIN 58.04
- ACLX 46.33
- Support Level
- MAIN $51.80
- ACLX $99.95
- Resistance Level
- MAIN $52.89
- ACLX $107.37
- Average True Range (ATR)
- MAIN 0.75
- ACLX 5.90
- MACD
- MAIN 0.05
- ACLX -0.23
- Stochastic Oscillator
- MAIN 77.81
- ACLX 35.66
About MAIN Main Street Capital Corporation
Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancing's, and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants, and other securities of the lower middle market and middle market companies based in the United States. Business functioned through the U.S. region and it derives the majority of its income from the source of fees, commission, and interest.
About ACLX Arcellx Inc.
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.